These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21658633)

  • 61. Cystic fibrosis frequently asked questions.
    Lim SZ; Fitzgerald DA
    Paediatr Respir Rev; 2015 Mar; 16(2):110-1. PubMed ID: 25973462
    [No Abstract]   [Full Text] [Related]  

  • 62. Combination antibiotic susceptibility testing in cystic fibrosis.
    MacKenzie FM; Griffiths C; Dempsey O; Devereux G; Gould IM
    Lancet; 2005 Nov; 366(9498):1693; author reply 1693-4. PubMed ID: 16291059
    [No Abstract]   [Full Text] [Related]  

  • 63. State of progress in treating cystic fibrosis respiratory disease.
    Flume PA; Van Devanter DR
    BMC Med; 2012 Aug; 10():88. PubMed ID: 22883684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases.
    Haack A; Aragão GG; Novaes MR
    World J Gastroenterol; 2013 Dec; 19(46):8552-61. PubMed ID: 24379572
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Defining antimicrobial resistance in cystic fibrosis.
    Kidd TJ; Canton R; Ekkelenkamp M; Johansen HK; Gilligan P; LiPuma JJ; Bell SC; Elborn JS; Flume PA; VanDevanter DR; Waters VJ;
    J Cyst Fibros; 2018 Nov; 17(6):696-704. PubMed ID: 30266518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Advancing outcome measures for the new era of drug development in cystic fibrosis.
    Mayer-Hamblett N; Ramsey BW; Kronmal RA
    Proc Am Thorac Soc; 2007 Aug; 4(4):370-7. PubMed ID: 17652504
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria.
    Starner TD; McCray PB; ;
    Ann Intern Med; 2005 Dec; 143(11):816-22. PubMed ID: 16330793
    [No Abstract]   [Full Text] [Related]  

  • 68. Therapeutic strategies in pneumonia: going beyond antibiotics.
    Müller-Redetzky H; Lienau J; Suttorp N; Witzenrath M
    Eur Respir Rev; 2015 Sep; 24(137):516-24. PubMed ID: 26324814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bacterial pneumonia infection in pregnancy.
    Ashby T; Staiano P; Najjar N; Louis M
    Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt A):26-33. PubMed ID: 35970746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms.
    Murphy MP; Caraher E
    Drugs R D; 2016 Mar; 16(1):1-17. PubMed ID: 26747453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Updates on the Management of Cystic Fibrosis: Development of Modulators and Advancement of Antibiotic Therapies.
    Boyd C; Auth RD; Blundin M; Banerjee D
    R I Med J (2013); 2021 Sep; 104(7):20-25. PubMed ID: 34437661
    [No Abstract]   [Full Text] [Related]  

  • 72. Alternative and/or integrative therapies for pneumonia under development.
    Cazzola M; Page CP; Matera MG
    Curr Opin Pulm Med; 2004 May; 10(3):204-10. PubMed ID: 15071372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibiotic treatment of cystic fibrosis.
    Marino JT
    J Pediatr; 1981 Mar; 98(3):511. PubMed ID: 7205477
    [No Abstract]   [Full Text] [Related]  

  • 74. Drug interactions and treatment burden as survival improves.
    Nichols DP; Kuk KN; Nick JA
    Curr Opin Pulm Med; 2015 Nov; 21(6):617-25. PubMed ID: 26390336
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery at the bedside.
    Oren O
    Ann Intern Med; 2011 Nov; 155(9):643. PubMed ID: 22041956
    [No Abstract]   [Full Text] [Related]  

  • 76. Intravenous Antibiotic Durations: "Short" Wins Again.
    Schroeder AR; Desai S; Hess LM
    Hosp Pediatr; 2022 Jul; 12(7):e269-e272. PubMed ID: 35726557
    [No Abstract]   [Full Text] [Related]  

  • 77. Discovery and development of new antibiotics: the problem of antibiotic resistance.
    Silver LL; Bostian KA
    Antimicrob Agents Chemother; 1993 Mar; 37(3):377-83. PubMed ID: 8460908
    [No Abstract]   [Full Text] [Related]  

  • 78. [New developments in antibiotic therapy].
    BUMILLER OE
    Zahnarztl Rundsch; 1954 Apr; 63(8):230-4. PubMed ID: 13179578
    [No Abstract]   [Full Text] [Related]  

  • 79. New antibiotic development: the need versus the costs.
    Welte T
    Lancet Infect Dis; 2016 Apr; 16(4):386-7. PubMed ID: 26852725
    [No Abstract]   [Full Text] [Related]  

  • 80. Antibiotic Resistance: From the Bench to Patients.
    Gajdács M; Albericio F
    Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31461842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.